Safety profile of sintilimab and establishment of a risk prediction model based on medical records of 337 cases
Int. Journal of Clinical Pharmacology and Therapeutics · 01.10.2026 · 64 (10) · 537-547
DOI: 10.5414/cp205009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.10.2026. Verfasst von Chengting Rong und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Rong, C., Zhang, H., Hu, L., Li, Y., Xin, J., & Wu, X. (2026). Safety profile of sintilimab and establishment of a risk prediction model based on medical records of 337 cases. Int. Journal of Clinical Pharmacology and Therapeutics, 64(10), 537-547. https://doi.org/10.5414/cp205009
Vancouver
Rong C, Zhang H, Hu L, Li Y, Xin J, Wu X. Safety profile of sintilimab and establishment of a risk prediction model based on medical records of 337 cases. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(10):537-547. doi:10.5414/cp205009
BibTeX
@article{Rong2026,
author = {Rong, Chengting and Zhang, Hong and Hu, Ling and Li, Yingning and Xin, Jianjuan and Wu, Xinan},
title = {Safety profile of sintilimab and establishment of a risk prediction model based on medical records of 337 cases},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {10},
pages = {537--547},
doi = {10.5414/cp205009}
}
EUVIMED